Interferon antibodies diminish response to peginterferon-based therapy in the immune tolerant phase of chronic hepatitis b infection: results from the hepatitis b research network (hbrn)
HEPATOLOGY（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined